Our results, taken together, indicate IKKβ inhibition attenuates gene expression changes associated with TGF–β/TNF–α-induced RPE–EMT, including alterations in the expression of multiple AMD-associated risk factors. This evidence concerns the gene TGFB1 and age-related macular degeneration.